HK1211839A1 - Pneumococcal vaccine containing pneumococcal surface protein - Google Patents

Pneumococcal vaccine containing pneumococcal surface protein

Info

Publication number
HK1211839A1
HK1211839A1 HK15112687.6A HK15112687A HK1211839A1 HK 1211839 A1 HK1211839 A1 HK 1211839A1 HK 15112687 A HK15112687 A HK 15112687A HK 1211839 A1 HK1211839 A1 HK 1211839A1
Authority
HK
Hong Kong
Prior art keywords
pneumococcal
surface protein
vaccine containing
pneumococcal vaccine
pneumococcal surface
Prior art date
Application number
HK15112687.6A
Other languages
English (en)
Chinese (zh)
Inventor
明田幸宏
樸貞玉
大石和德
Original Assignee
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka filed Critical Univ Osaka
Publication of HK1211839A1 publication Critical patent/HK1211839A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15112687.6A 2012-09-19 2015-12-24 Pneumococcal vaccine containing pneumococcal surface protein HK1211839A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012206039 2012-09-19
PCT/JP2013/058401 WO2014045621A1 (ja) 2012-09-19 2013-03-22 肺炎球菌表面タンパク質ａを含む肺炎球菌ワクチン

Publications (1)

Publication Number Publication Date
HK1211839A1 true HK1211839A1 (en) 2016-06-03

Family

ID=50340954

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112687.6A HK1211839A1 (en) 2012-09-19 2015-12-24 Pneumococcal vaccine containing pneumococcal surface protein

Country Status (7)

Country Link
US (1) US9938326B2 (ja)
EP (1) EP2910251B1 (ja)
JP (2) JP5854537B2 (ja)
CN (2) CN104812405A (ja)
ES (1) ES2763415T3 (ja)
HK (1) HK1211839A1 (ja)
WO (1) WO2014045621A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3294762T (pt) 2015-05-11 2022-03-21 Impossible Foods Inc Constructos de expressão e métodos de modificar geneticamente levedura metilotrófica
US20180223326A1 (en) * 2015-06-18 2018-08-09 The Research Foundation For Microbial Diseases Of Osaka University Method For Measuring Complement-Dependent Bactericidal Function With Respect To Pneumococci
CN110381992A (zh) * 2016-12-03 2019-10-25 Uab研究基金会 组合了肺炎球菌表面蛋白A的选择的α螺旋结构域和脯氨酸富集结构域的肺炎球菌疫苗
US20210062138A1 (en) * 2018-01-22 2021-03-04 The Research Foundation For Microbial Diseases Of Osaka University Medium for culturing pneumococcal samples
CN113631186A (zh) * 2019-03-29 2021-11-09 国立大学法人东京大学 肺炎球菌表面蛋白
BR112021021154A2 (pt) 2019-04-25 2021-12-14 Impossible Foods Inc Cepas e métodos para produção de proteínas que contêm heme
CN110898217B (zh) * 2019-11-28 2023-03-28 遵义医科大学珠海校区 一种肺炎链球菌疫苗及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220812A3 (en) 1985-09-06 1988-11-09 Rodime PLC High capacity disc drive
US6232116B1 (en) 1991-02-15 2001-05-15 University Of Alabama At Birmingham Research Foundation Oral administration of pneumococcal antigens
US6592876B1 (en) 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5980909A (en) 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5965141A (en) 1991-02-15 1999-10-12 Uab Research Foundation Epitopic regions of pneumococcal surface protein a
US6042838A (en) 1991-02-15 2000-03-28 Uab Research Foundation immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
US6231870B1 (en) 1995-06-02 2001-05-15 Uab Research Foundation Oral administration of pneumoccal antigens
JP3327650B2 (ja) 1993-04-15 2002-09-24 キヤノン株式会社 記録装置
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
DK0571538T5 (da) 1991-02-15 2002-03-04 Uab Research Foundation Strukturgen for pneumokokprotein
US5679768A (en) 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US6027734A (en) 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US5955089A (en) 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
US6004802A (en) 1995-06-02 1999-12-21 University Of Alabama At Birmingham Oral administration of pneumococcal antigens
US7078042B2 (en) 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
WO2000076587A1 (en) 1999-06-16 2000-12-21 Aventis Pasteur Antibody-based treatment for streptococcus pneumoniae infection
US8084235B2 (en) 2003-03-13 2011-12-27 Glaxosmithkline Biologicals S.A. Purification process for bacterial cytolysin
CA2808919C (en) * 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
EP2687228B1 (en) * 2007-06-26 2017-07-19 GlaxoSmithKline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
CN102695523A (zh) 2009-09-10 2012-09-26 诺华有限公司 针对呼吸道疾病的组合疫苗
JP5730723B2 (ja) 2011-09-08 2015-06-10 中国電力株式会社 Ｐｃカットアウト用仮送電具

Also Published As

Publication number Publication date
JP2016047842A (ja) 2016-04-07
EP2910251B1 (en) 2019-11-20
JP6072210B2 (ja) 2017-02-01
US9938326B2 (en) 2018-04-10
ES2763415T3 (es) 2020-05-28
JP5854537B2 (ja) 2016-02-09
CN109289045A (zh) 2019-02-01
CN104812405A (zh) 2015-07-29
WO2014045621A1 (ja) 2014-03-27
US20150320851A1 (en) 2015-11-12
EP2910251A4 (en) 2016-05-25
EP2910251A1 (en) 2015-08-26
JPWO2014045621A1 (ja) 2016-08-18

Similar Documents

Publication Publication Date Title
HK1207967A1 (en) Vaccine
SG11201400432VA (en) Polypeptide vaccine
PL2647387T3 (pl) Kompozycja szczepionki
HK1211839A1 (en) Pneumococcal vaccine containing pneumococcal surface protein
EP2876161A4 (en) VACCINE
GB201223386D0 (en) Vaccine
SG11201500396TA (en) Tumor vaccination
HK1249859A1 (zh) Pcsk9肽疫苗
HK1212730A1 (zh) 肽及包含它們的疫苗
HK1209138A1 (en) Peptides
EP2829281A4 (en) LPS VACCINE
GB201215005D0 (en) Stabilised meningitis vaccine
EP2701735A4 (en) LIQUID VACCINE COMPOSITIONS
EP2891497A4 (en) DNA VACCINATING VEGF-SPECIFIC EPITOP AND / OR ANGIOPOIETIN-2-SPECIFIC EPITOP
EP2822599A4 (en) VACCINE
GB201204868D0 (en) Peptides
EP2862873A4 (en) IGE PEPTIDE VACCINE
GB201202090D0 (en) Vaccine
GB201213672D0 (en) Protein
DK2846829T3 (en) Vaccine combinations
GB201217321D0 (en) Vaccine
GB201210226D0 (en) Vaccine
GB201206169D0 (en) Vaccine
GB201205599D0 (en) Vaccine
GB201215901D0 (en) Protein modification